BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36806386)

  • 1. The repertoire of copy number alteration signatures in human cancer.
    Tao Z; Wang S; Wu C; Wu T; Zhao X; Ning W; Wang G; Wang J; Chen J; Diao K; Chen F; Liu XS
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36806386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes.
    Khalil AIS; Khyriem C; Chattopadhyay A; Sanyal A
    BMC Bioinformatics; 2020 Apr; 21(1):147. PubMed ID: 32299346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
    Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
    Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CaSNP: a database for interrogating copy number alterations of cancer genome from SNP array data.
    Cao Q; Zhou M; Wang X; Meyer CA; Zhang Y; Chen Z; Li C; Liu XS
    Nucleic Acids Res; 2011 Jan; 39(Database issue):D968-74. PubMed ID: 20972221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
    Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
    Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.
    Wang S; Li H; Song M; Tao Z; Wu T; He Z; Zhao X; Wu K; Liu XS
    PLoS Genet; 2021 May; 17(5):e1009557. PubMed ID: 33945534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
    Yu Z; Li A; Wang M
    BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.
    Kang M; Cho E; Jang J; Lee J; Jeon Y; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Investig Clin Urol; 2019 Jul; 60(4):227-234. PubMed ID: 31294131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
    Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
    J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
    Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
    PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures.
    Graham NA; Minasyan A; Lomova A; Cass A; Balanis NG; Friedman M; Chan S; Zhao S; Delgado A; Go J; Beck L; Hurtz C; Ng C; Qiao R; Ten Hoeve J; Palaskas N; Wu H; Müschen M; Multani AS; Port E; Larson SM; Schultz N; Braas D; Christofk HR; Mellinghoff IK; Graeber TG
    Mol Syst Biol; 2017 Feb; 13(2):914. PubMed ID: 28202506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number alteration features in pan-cancer homologous recombination deficiency prediction and biology.
    Yao H; Li H; Wang J; Wu T; Ning W; Diao K; Wu C; Wang G; Tao Z; Zhao X; Chen J; Sun X; Liu XS
    Commun Biol; 2023 May; 6(1):527. PubMed ID: 37193789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
    Wang G; Anastassiou D
    Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signatures of copy number alterations in human cancer.
    Steele CD; Abbasi A; Islam SMA; Bowes AL; Khandekar A; Haase K; Hames-Fathi S; Ajayi D; Verfaillie A; Dhami P; McLatchie A; Lechner M; Light N; Shlien A; Malkin D; Feber A; Proszek P; Lesluyes T; Mertens F; Flanagan AM; Tarabichi M; Van Loo P; Alexandrov LB; Pillay N
    Nature; 2022 Jun; 606(7916):984-991. PubMed ID: 35705804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
    Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
    Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of genomic copy number alteration emphasizing a restriction site-based strategy of genome re-sequencing.
    Zheng C; Miao X; Li Y; Huang Y; Ruan J; Ma X; Wang L; Wu CI; Cai J
    Bioinformatics; 2013 Nov; 29(22):2813-21. PubMed ID: 23962614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer.
    Nguyen B; Wong NC; Semple T; Clark M; Wong SQ; Leslie C; Mirzai B; Millward M; Meehan K; Lim AM
    Sci Rep; 2021 Feb; 11(1):4016. PubMed ID: 33597619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
    Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
    Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.